How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Podcasts
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI.
Podcasts
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic care
Podcasts
Teresa Dail, AHRMM’s 2018 Chair, shares AHRMM’s definition of clinical integration and why a clinically integrated supply chain is important to her
Podcasts
Having conversations with clinicians can be difficult, Howard Mann, a 30 year supply chain professional, discusses how to prepare for physician con
Podcasts
It doesn’t take a deadly pandemic like Ebola to put your supply chain—and your staff and patients--at risk.
Podcasts
Jake Crampton, chief executive officer, Medspeed discusses intra-company logistics, which is a relatively new concept that is all about leveraging